If you liked this article you might like

Pluristem Therapeutics (PSTI) Stock Surges on FDA Orphan Drug Designation
Pluristem, Capricor Lead Regenerative Space Says Raymond James Analyst
Pluristem CEO Seeing the Future in 3D Cells